Investing.com - Collplant ADR reported on Thursday first quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Collplant ADR announced earnings per share of $0.88 on revenue of $14.5M. Analysts polled by Investing.com anticipated EPS of $0.495 on revenue of $10.06M.
Collplant ADR shares are up 11% from the beginning of the year, still down 35.41% from its 52 week high of $24.26 set on February 11. They are under-performing the S&P Merval which is up 12.1% from the start of the year.
Collplant ADR shares gained 1.44% in intra-day trade following the report.
Collplant ADR follows other major Healthcare sector earnings this month
Collplant ADR's report follows an earnings beat by Pfizer on May 4, who reported EPS of $0.93 on revenue of $14.58B, compared to forecasts EPS of $0.7759 on revenue of $13.65B.
AbbVie had beat expectations on April 30 with first quarter EPS of $2.95 on revenue of $13.01B, compared to forecast for EPS of $2.81 on revenue of $12.77B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar